tetradecanoylphorbol acetate has been researched along with Mesothelioma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhandary, YP; Florova, G; Idell, S; Koenig, K; Marudamuthu, AS; Shetty, P; Shetty, RS; Shetty, S; Shetty, SK; Tucker, T; Velusamy, T | 1 |
Kalinovsky, T; Monterrey, JC; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
Idell, S; Johnson, A; Kumar, A; Pueblitz, S; Shetty, S | 1 |
Fitzgerald, DJ; Linnainmaa, K; Pelin, K; Piccoli, C; Tuomi, T; Vanhala, E; Yamasaki, H | 1 |
Idell, S; Kumar, A; Shetty, S | 1 |
Heidtmann, HH; Moldenhauer, G; Schirrmacher, V; Schwartz-Albiez, R; Wolf, D | 1 |
Collins, CL; Cook, CD; Fink, L; Granger, J; Hsu, PL; Hsu, SM; Ordonez, NG; Schaefer, R; Xie, SS | 1 |
7 other study(ies) available for tetradecanoylphorbol acetate and Mesothelioma
Article | Year |
---|---|
Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.
Topics: Blotting, Northern; Blotting, Western; Carcinogens; Cells, Cultured; Cycloheximide; Epithelium; Gene Expression Regulation; Humans; Mesothelioma; Plasminogen Activator Inhibitor 1; Pleura; Pleural Neoplasms; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transforming Growth Factor beta | 2010 |
Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Culture Media; Cytokines; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lipopolysaccharides; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mesothelioma; Neoplasm Metastasis; Tetradecanoylphorbol Acetate; Time Factors | 2009 |
Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis.
Topics: Cell Cycle; Cell Division; Cell Line; Gene Expression; Humans; Immunohistochemistry; Iodine Radioisotopes; Kinetics; Mesothelioma; Methionine; Protein Biosynthesis; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; RNA, Messenger; Tetradecanoylphorbol Acetate; Thymidine; Transcription, Genetic; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator | 1995 |
Gap junctional intercellular communication of primary and asbestos-associated malignant human mesothelial cells.
Topics: Asbestos; Cell Communication; Cells, Cultured; Connexins; Epithelial Cells; Epithelium; Gene Expression; Humans; Intercellular Junctions; Membrane Proteins; Mesothelioma; Pleural Neoplasms; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.
Topics: Base Sequence; Binding Sites; Cycloheximide; Dactinomycin; Epithelial Cells; Epithelium; Gene Expression; Globins; Humans; Lipopolysaccharides; Mesothelioma; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Pleural Neoplasms; Protein Synthesis Inhibitors; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; RNA; RNA-Binding Proteins; RNA, Messenger; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator | 1997 |
Three types of human lung tumour cell lines can be distinguished according to surface expression of endogenous urokinase and their capacity to bind exogenous urokinase.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Humans; Immunochemistry; Kinetics; Lung Neoplasms; Mesothelioma; Protein Binding; Tetradecanoylphorbol Acetate; Urokinase-Type Plasminogen Activator | 1992 |
Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers, Tumor; Carcinoembryonic Antigen; Cell Cycle; Diagnosis, Differential; Humans; In Situ Hybridization; Lewis X Antigen; Lung; Lung Neoplasms; Mesothelioma; Receptors, Cell Surface; Receptors, Thrombin; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |